Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Consider this

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Oct 26, 2023 2:02pm

64 Views

Post# 35702614

RE:RE:RE:Consider this

I just looked at Cytodyn that has 930M shares outstanding, no products, no sales, no pipeline, runned by fellons and guess what 150M market cap.... big volumes...OTC don't bother with Nasdaq listing either... maybe it's their new role model since it works...

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland